Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

NCT00798317 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitreomacular Adhesion

Interventions

DRUG: Ocriplasmin 125µg
DRUG: Placebo

Sponsor

ThromboGenics